Updated Jul 16, 2026
Winningham Rick E has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $662K.

Rick E. Winningham is the Chief Executive Officer and a Director of Theravance Biopharma, Inc., a biopharmaceutical company specializing in organ-selective medicines. He has also held significant roles at Jazz Pharmaceuticals plc, contributing to the development of innovative therapies.
| Role | Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 2.7K | $241.57 | $662K |
| 2026-05-27 | JAZZ | Jazz Pharmaceuticals plc | M — Option exercise | 3.4K | $138.08 | $472K |
| 2026-05-22 | tbph | Theravance Biopharma, Inc. | F — Tax withholding / forfeiture | 20.0K | $16.55 | $332K |
| 2026-04-03 | tbph | Theravance Biopharma, Inc. | A — Grant or award | 75.0K | $0.00 | |
| 2026-02-25 | tbph | Theravance Biopharma, Inc. | F — Tax withholding / forfeiture | 75.0K | $19.66 | $1.47M |
| 2025-08-20 | tbph | Theravance Biopharma, Inc. | F — Tax withholding / forfeiture | 15.4K | $13.39 | $206K |
| 2025-08-07 | JAZZ | Jazz Pharmaceuticals plc | F — Tax withholding / forfeiture | 1.8K | $111.25 | $201K |
| 2025-08-07 | JAZZ | Jazz Pharmaceuticals plc | A — Grant or award | 3.5K | $0.00 | |
| 2025-06-23 | tbph | Theravance Biopharma, Inc. | G — Bona-fide gift | 20.0K | $0.00 | |
| 2025-06-13 | tbph | Theravance Biopharma, Inc. | G — Bona-fide gift | 9.6K | $0.00 | |
| 2025-06-13 | tbph | Theravance Biopharma, Inc. | G — Bona-fide gift | 9.6K | $0.00 | |
| 2025-05-20 | tbph | Theravance Biopharma, Inc. | F — Tax withholding / forfeiture | 15.4K | $9.45 | $145K |
| 2024-11-22 | tbph | Theravance Biopharma, Inc. | F — Tax withholding / forfeiture | 16.0K | $9.97 | $159K |
| 2024-11-19 | tbph | Theravance Biopharma, Inc. | A — Grant or award | 3.2K | $9.57 | $31K |
Rick E. Winningham is the Chief Executive Officer and a Director of Theravance Biopharma, Inc., a biopharmaceutical company specializing in organ-selective medicines. He has also held significant roles at Jazz Pharmaceuticals plc, contributing to the development of innovative therapies.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($662K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Winningham Rick E profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.